Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 1440-1445, October 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGuire, W. L.
Right arrow Articles by Julian, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGuire, W. L.
Right arrow Articles by Julian, J. A.

Comparison of Macromolecular Binding of Estradiol in Hormone-dependent and Hormone-independent Rat Mammary Carcinoma1

William L. McGuire and Jo Anne Julian

Department of Physiology and Medicine, The University of Texas Medical School at San Antonio, San Antonio, Texas 78229

In rat mammary carcinoma, 2 types of cytoplasmic estradiol-binding sites, A and B, are present. The A sites are excluded on Sephade x G-100 chromatography, sediment at 8 S and 4 S in a low-ionic-strength sucrose gradient or at 4 S alone in a high-ionic-strength sucrose gradient, and form an insoluble complex with protamine sulfate. They have a very high affinity for estradiol (Kd ~ 1.2 x 10-10 M) and do not bind nonestrogenic steroids. The B sites are not seen on Sephadex G-100 chromatography, sediment at 4 S in a sucrose gradient, do not interact with protamine sulfate, and exhibit much weaker binding (Kd ~ 1 x 10-7 M) than the A sites. Only hormone-dependent tumors exhibit the highly specific A sites, while B sites are present in both hormone-dependent and autonomous tumors. Specific binding of estradiol within the nucleus is confined to hormone-dependent tumors.

1 This work was supported in part by USPHS Grant CA 11378 and American Cancer Society Grant T-510.

Received 3/23/71. Accepted 5/28/71.




This article has been cited by other articles:


Home page
ScienceHome page
W. L. Mcguire, K. Huff, A. Jennings, and G. C. Chamness
Mammary Carcinoma: A Specific Biochemical Defect in Autonomous Tumors
Science, January 21, 1972; 175(4019): 335 - 336.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.